Ken Griffin Context Therapeutics Inc. Call Options Transaction History
Citadel Advisors LLC
- $505 Billion
- Q3 2024
Call Options
0 transactions
| Quarter | Operation | Price Per call | calls change | calls Held | SEC Form |
|---|
Others Institutions Holding CNTX
# of Institutions
45Shares Held
56.9MCall Options Held
0Put Options Held
0-
Nextech Invest Ag7.42MShares$8.46 Million2.37% of portfolio
-
Deep Track Capital, LP Greenwich, CT7.42MShares$8.46 Million0.54% of portfolio
-
Avidity Partners Management LP Dallas, TX7.42MShares$8.46 Million0.89% of portfolio
-
Great Point Partners LLC Greenwich, CT6.93MShares$7.91 Million6.28% of portfolio
-
Blue Owl Capital Holdings LP New York, NY5.41MShares$6.17 Million3.5% of portfolio
About Context Therapeutics Inc.
- Ticker CNTX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 15,966,100
- Market Cap $18.2M
- Description
- Context Therapeutics Inc., a clinical-stage biopharmaceutical company, develops products for the treatment of cancer for women in the United States. Its lead product candidate is onapristone extended release (ONA-XR), a potent and selective antagonist of the progesterone receptor that is linked to resistance for various classes of cancer therape...